Engineering Cancer I: Mechanistic Studies | AIChE

Other Sites & Tools

Technical Groups

Engineering Cancer I: Mechanistic Studies

Chair(s)

Zangle, T., University of Utah

Co-chair(s)

Quinones-Diaz, B., University of Texas-Austin

This session highlights the contributions of chemical engineers who are changing the future of cancer diagnosis and treatment. This session explores exosomes, metastasis, development of drug resistance, evasion of the immune response, the impact of mass transport on tumor progression, dormancy, and recurrence and treatments for cancer including immunotherapy and precision medicine.

Presentations

12:30 PM
(526a) The Effects of Intratumoral Heterogeneity on Metastasis of Triple-Negative Breast Cancer Cells
12:48 PM
(526b) The Effects of Palmitate-Induced IRE1? Activation in DNA Double Strand Break Repair and the Development of Chemotolerant Breast Cancer Cells
1:06 PM
(526c) Macrophages Aggregate and Cooperate to Phagocytose Cohesive Tumor Cell Targets in Engineered Immuno-Tumoroids and Solid Tumors
1:24 PM
(526d) Mechanistic Characterization of Homologous Recombination in BRCA2 Mutant Cancers
1:42 PM
(526e) Modeling Cancer Dormancy and Recurrence with the Theory of Birth-Death Processes
2:00 PM
(526g) Machine-Learning Based Prediction of Membranolytic Peptides with Anticancer Activities
2:18 PM
(526h) Caspase-Dependent HDAC4 Translocation Due to Microsecond Pulsed Electric Field (?sPEF) Exposure of Glioblastoma Cells

Topics 

Medicine
Transport Phenomena

Checkout

Paper abstracts are public but to access Extended Abstracts, you must first purchase the conference proceedings.

Checkout

Do you already own this?

Pricing

Individuals

AIChE Pro Members $150.00
AIChE Emeritus Members $105.00
AIChE Graduate Student Members Free
AIChE Undergraduate Student Members Free
AIChE Explorer Members $225.00
Non-Members $225.00

More Conference Links